The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Abstract
Objective: To identify patients’ perceptions of the value of psilocybin as a treatment for depression. Method: Twenty patients enrolled in an open-label trial of psilocybin for treatment-resistant depression participated in a semistructured interview at 6-month follow-up. Thematic analysis was used to identify patients’ experiences of the treatment and how it compared with previous treatments. Results: Two main change processes were identified in relation to the treatment. The first concerned change from disconnection (from self, others, and world) to connection, and the second concerned change from avoidance (of emotion) to acceptance. A third theme concerned comparison between psilocybin and conventional treatments. Patients reported that medications and some short-term talking therapies tended to reinforce their sense of disconnection and avoidance, whereas treatment with psilocybin encouraged connection and acceptance. Conclusions: These results suggest that psilocybin treatment for depression may work via paradigmatically novel means, antithetical to antidepressant medications, and some short-term talking therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A limitation of the CEQ is that it measures challenging emotions, memories, or both without addressing their potential resolution. Therefore, it cannot assess the potential value of overcoming any emotional challenges experienced under the influence of psychedelics (Watts et al., 2017).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Watts et al., 2017
In the citing paper
“Therapeutic outcomes appear strongly influenced by psychological “set” (mindset, expectations, preparation), environmental “setting,” and structured post-session integration (96, 99, 107, 108), highlighting the central role of context, support, and integration in optimizing benefit.”
From The therapeutic role of self-transcendence in moral injury recovery: theory, mechanisms, and clinical implications (2026) · cites this paper as [99]
In the citing paper
“In qualitative interviews, participants identified this tri-dimensional factor as a key element underlying the therapeutic effect of PAT [61, 62], including reduced craving and substance use in individuals with addiction [62].”
In the citing paper
“These emotions largely cohered with previous observations in other psilocybin studies (36–42).”
In the citing paper
“These outcomes are in line with previous reports from participants of clinical trials, who described a notable shift from emotional avoidance to acceptance, after receiving psilocybin-assisted psychotherapy for treatment-resistant depression [57].”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [57]
In the citing paper
“Their use can help individuals break through emotional barriers, confront past traumas, and develop a deeper sense of self-awareness and connection with others (Watts et al. 2017;Carhart-Harris et al. 2018).”
From Authenticity and Love Drugs: Insights from Psychedelic Therapy (2026) · cites this paper as Watts et al. 2017
In the citing paper
“After treatment, many reported to be able to “re-connect” with family members, friends, strangers, and even people who had wronged them.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
In the citing paper
“Patients identified this increased connection as one of two main change processes in relation to treatment (32)”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
In the citing paper
“Yet, the same patients reported that they experienced a sense of disconnection from others as particularly distressing before psilocybin-assisted treatment (32).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
Citations
Cites
(1998) · Sage eBooks · Cited by 38,631
Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory
Corbin, J., & Strauss, A. (2008) · SAGE · doi:10.4135/9781452230153 · Cited by 12,136
Successful Qualitative Research: A practical guide for beginners
Jamieson, J., Braun, V., & Clarke, V. (2014) · QMiP Bulletin · doi:10.53841/bpsqmip.2014.1.18.39 · Cited by 6,673
Successful qualitative research: A practical guide for beginners
(2016) · QMiP Bulletin · doi:10.53841/bpsqmip.2016.1.21.48 · Cited by 4,033
Client-Centered Therapy: Its Current Practice, Implications and Theory
Rogers, C. R. (1951) · Cited by 2,416
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 4×
“…formal, quantitative analyses of the utility of psilocybin (Carhart-Harris, Bolstridge, et al., 2016; Carhart-Harris, 2017; Gasser et al., 2014; Griffiths et al., 2016; Ross et al., 2016) and should help inform and enrich understanding of this novel treatment and its mechanisms of action,…”
InfluentialClient-centered therapy; its current practice, implications, and theory.
Miles, D. W. (1952) · Psychological Bulletin · doi:10.1037/h0053095 · Cited by 2,122
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
How important are the common factors in psychotherapy? An update
Wampold, B. E. (2015) · World Psychiatry · doi:10.1002/wps.20238 · Cited by 1,728 · cited 1×
“…to play a role in determining treatment outcomes (Greenberg, Constantino, & Bruce, 2006; Visla, Constantino, Newkirk, Ogrodniczuk, & Söchting, 2016; Wampold, 2015; Wampold et al., 2005) and it is likely that many of the patients in this trial had positive expectations and/or experienced a positive…”
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Research works printed but not linked: 5
- Frankl V. E., 1961, Confinia Psychiatrica, 4, 99
- Goldsmith N., 2011, Psychedelic healing: The promise of entheogens for psychotherapy and spiritual development
- Grof S., 1980, LSD psychotherapy
- Meckel Fischer F., 2015, Therapy with substance: Psycholytic psychotherapy in the twenty first century
- Stolaroff M., 2004, The secret chief revealed: Conversations with Leo Zeff
Cited by
Sorted by citations
Items 201–300 of 585
A Phenomenology of Challenging Psychedelic Experiences: From Relational Trauma to Relational Healing
Guthrie, L. (2021) · Cited by 19
Schenberg, E. E., & Gerber, K. (2022) · Transcultural Psychiatry · doi:10.1177/13634615211062962 · Cited by 21
McMillan, R. M., & Jordens, C. F. C. (2022) · Medicine Health Care and Philosophy · doi:10.1007/s11019-022-10070-7 · Cited by 19
Will psilocybin lose its magic in the clinical setting?
Hayes, C., Wahba, M., & Watson, S. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221090822 · Cited by 20
Forstmann, M., Kettner, H., Sagioglou, C., Irvine, A., Gandy, S., Carhart-Harris, R. L., & Luke, D. P. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811221146356 · Cited by 21
Self-citationMichael, P., Luke, D. P., & Robinson, O. C. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1083356 · Cited by 22
Cowley‐Court, T., Chenhall, R. D., Sarris, J. J., Bouso, J. C., Tófoli, L. F., Opaleye, E. S., Schubert, V., & Perkins, D. (2023) · Psychoactives · doi:10.3390/psychoactives2020014 · Cited by 20
Perkins, D., Opaleye, E. S., Bouso, J. C., Tófoli, L. F., Sarris, J. J., Schubert, V., Ruffell, S., & Šimonová, H. (2023) · Psychoactives · doi:10.3390/psychoactives2040017 · Cited by 21
Modlin, N. L., Creed, M., Sarang, M., Maggio, C., Rucker, J., & Williamson, V. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s432537 · Cited by 23
Psychedelics and the ‘inner healer’: Myth or mechanism?
Peill, J. M., Marguilho, M., Erritzøe, D., Barba, T., Greenway, K. T., Rosas, F. E., Timmermann, C., & Carhart-Harris, R. L. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241239206 · Cited by 24
Self-citationDo psychedelics facilitate emergence of unconscious psychological processes
Lindegaard, T. (2023) · Psychodynamic Psychiatry · doi:10.1521/pdps.2023.51.3.270 · Cited by 18
Psychedelic risks and benefits: A cross-sectional survey study
Goldy, S. P., Du, B. A., Rohde, J. S., Nayak, S. M., Strickland, J. C., Ehrenkranz, R. C., Levine, M., Barrett, F. S., & Yaden, D. B. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241292951 · Cited by 18
How Psychedelic-Assisted Treatment Works in the Bayesian Brain
Villiger, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.812180 · Cited by 21
Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample
Mellner, C., Dahlén, M., & Simonsson, O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811353 · Cited by 18
Newton, K., & Moreton, S. G. (2022) · Ecopsychology · doi:10.1089/eco.2022.0044 · Cited by 19
How Do Psychedelics Reduce Fear of Death?
Letheby, C. (2024) · Neuroethics · doi:10.1007/s12152-024-09564-3 · Cited by 19
Traumatic Psychedelic Experiences
Calder, A. E., Diehl, V. J., & Hasler, G. (2025) · Current topics in behavioral neurosciences · doi:10.1007/7854_2025_579 · Cited by 19
Ruban, A., & Kołodziej, A. (2018) · Neuropsychiatria i Neuropsychologia · doi:10.5114/nan.2018.81249 · Cited by 21
Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments
Hutchison, C. A., & Bressi, S. (2020) · Clinical Social Work Journal · doi:10.1007/s10615-019-00743-x · Cited by 17
Scheidegger, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_3 · Cited by 21
Lehto, R. H., Miller, M., & Sender, J. (2022) · Journal of Holistic Nursing · doi:10.1177/08980101211039086 · Cited by 17
Wang, Z., Robbins, B., Zhuang, R., Sandini, T. M., van Bruggen, R., Li, X., & Zhang, Y. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111243 · Cited by 17
Artru, E., & Rabeyron, T. (2021) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2021.03.013 · Cited by 20
Psychedelic Science of Spirituality and Religion: An Attachment-Informed Agenda Proposal
Cherniak, A. D., Brulin, J. G., Mikulincer, M., Östlind, S., Carhart-Harris, R. L., & Granqvist, P. (2022) · International Journal for the Psychology of Religion · doi:10.1080/10508619.2022.2148061 · Cited by 25
Self-citationGlynos, N. G., Aday, J. S., Kruger, D. J., Boehnke, K. F., Lake, S., & Lucas, P. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1349565 · Cited by 17
Walther, R. F. E., & van Schie, H. T. (2024) · Psychoactives · doi:10.3390/psychoactives3030026 · Cited by 20
Meling, D., Egger, K., Aicher, H., Redondo, J. J., Mueller, J., Dornbierer, J., Temperli, E., Vasella, E. A., Caflisch, L., Pfeiffer, D., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241282637 · Cited by 20
Armstrong, M., Castellanos, J. P., & Christie, D. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1346053 · Cited by 19
Psychedelics and environmental virtues
Kirkham, N., & Letheby, C. (2022) · Philosophical Psychology · doi:10.1080/09515089.2022.2057290 · Cited by 20
Vorobyeva, N. S., & Kozlova, A. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927984 · Cited by 20
Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach
Agin-Liebes, G., & Davis, A. K. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_282 · Cited by 20
Lyon, A. (2023) · doi:10.1093/oso/9780198843757.001.0001 · Cited by 20
Further education in psychedelic-assisted therapy – experiences from Switzerland
Aicher, H., Müller, F., & Gasser, P. (2025) · BMC Medical Education · doi:10.1186/s12909-025-06871-y · Cited by 18
The Impact of Awe on Existential Isolation: Evidence for Contrasting Pathways
Edwards, M., Helm, P. J., Pratscher, S. D., Bettencourt, B. A., & Arndt, J. (2023) · Personality and Social Psychology Bulletin · doi:10.1177/01461672221144597 · Cited by 17
Weiss, B., Sleep, C. E., Beller, N. M., Erritzøe, D., & Campbell, W. K. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00291 · Cited by 15
Psychedelics align brain activity with context
Stoliker, D., Novelli, L., Khajehnejad, M. A., Biabani, M., Greaves, M. D., Barta, T., Williams, M., Chopra, S., Bazin, O., Simonsson, O., et al. (2026) · Nature · doi:10.1038/s41586-026-10910-z · Cited by 18
Self-citationHearn, B. (2021) · The Journal of Humanistic Counseling · doi:10.1002/johc.12164 · Cited by 18
Postpartum depression: A role for psychedelics?
Jairaj, C., & Rucker, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221093793 · Cited by 16
Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness
Mograbi, D. C., Rodrigues, R. F. S., Bienemann, B., & Huntley, J. D. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01353-y · Cited by 17
Peck, S. K., Brewerton, T. D., Fisher, H., Trim, J., Shao, S., Modlin, N. L., Kim, J., Finn, D. M., & Kaye, W. H. (2025) · Journal of Eating Disorders · doi:10.1186/s40337-025-01274-2 · Cited by 15
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05502-y · Cited by 13
“In qualitative interviews, participants identified this tri-dimensional factor as a key element underlying the therapeutic effect of PAT [61, 62], including reduced craving and substance use in individuals with addiction [62].”
BackgroundThe experience of ‘treatment‐resistant’ depression: A qualitative meta‐synthesis
Crowe, M., Manuel, J., Carlyle, D., Thwaites, B., & Lacey, C. J. (2023) · International Journal of Mental Health Nursing · doi:10.1111/inm.13107 · Cited by 14
Yuan, W., Guo, T., Jiang, T., & Wang, F. (2024) · Computers in Human Behavior · doi:10.1016/j.chb.2024.108283 · Cited by 13
Rose, J. R. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00363 · Cited by 17
Forstmann, M., & Sagioglou, C. (2025) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2025.101992 · Cited by 15
Psychedelics and autobiographical memory – six open questions
Kangaslampi, S., & Lietz, M. P. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06771-5 · Cited by 14
Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands
Lutkajtis, A. (2021) · Journal of Psychedelic Studies · doi:10.1556/2054.2021.00162 · Cited by 15
The Relationship Between Psychedelic Use, Mystical Experiences, and Pro-Environmental Behaviors
Paterniti, K., Bright, S. J., & Gringart, E. (2022) · Journal of Humanistic Psychology · doi:10.1177/00221678221111024 · Cited by 15
Kuburi, S., Passa, A.-M. D., Tassone, V. K., Mahmood, R., Lalovic, A., Ladha, K. S., Dunlop, K., Rizvi, S. J., Demchenko, I., & Bhat, V. (2022) · Chronic Stress · doi:10.1177/24705470221115342 · Cited by 14
Mohamed, A., Touheed, S., Ahmed, M., Hor, M., & Fatima, S. (2022) · Cureus · doi:10.7759/cureus.30919 · Cited by 17
Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
Roseman, L., Preller, K. H., Fotiou, E., & Winkelman, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.979764 · Cited by 13
Psychedelic therapy as reality transformation: A phenomenological approach
Petrement, M. S. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00231 · Cited by 12
On Redescribing the Indescribable: Trauma, Psychoanalysis and Psychedelic Therapy
Modlin, N. L., Stubley, J., Maggio, C., & Rucker, J. (2023) · British Journal of Psychotherapy · doi:10.1111/bjp.12852 · Cited by 11
Carlisle, N. A., Dourron, H. M., MacCarthy, S., Zarrabi, A. J., & Hendricks, P. S. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2022.0018 · Cited by 15
Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts
Graziosi, M., Singh, M., Nayak, S. M., & Yaden, D. B. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2255274 · Cited by 15
Acceptance as a possible link between past psychedelic experiences and psychological flexibility
Krabbe, A., Sikka, P., & Jylkkä, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-75595-8 · Cited by 15
Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
Liebnau, J., Betzler, F., & Kerber, A. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811241312866 · Cited by 13
Schmidt, T. T., Reiche, S., Hage, C. L. C., Bermpohl, F., & Majić, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-78527-4 · Cited by 12
Classic Psychedelics and Human–Animal Relations
Pöllänen, E., Osika, W., Stenfors, C. U. D., & Simonsson, O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19138114 · Cited by 11
Assessing potential of psilocybin for depressive disorders
Kozak, Z., Johnson, M. W., & Aaronson, S. T. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2273493 · Cited by 11
Johansen, L., Liknaitzky, P., Nedeljkovic, M., Mastin-Purcell, L., & Murray, G. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01930-7 · Cited by 11
“These outcomes are in line with previous reports from participants of clinical trials, who described a notable shift from emotional avoidance to acceptance, after receiving psilocybin-assisted psychotherapy for treatment-resistant depression [57].”
ResultThe potential of psilocybin use to enhance well-being in healthy individuals – A scoping review
Wiepking, L., de Bruin, E. J., & Ghiţă, A. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00244 · Cited by 12
Exploring the transformative potential of out-of-body experiences: A pathway to enhanced empathy
Weiler, M., Acunzo, D. J., Cozzolino, P. J., & Greyson, B. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105764 · Cited by 11
Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder
Miller, C., & Zoladz, P. R. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002237 · Cited by 13
Emerging Psychedelic-Assisted Therapies: Implications for Nursing Practice
Denis-Lalonde, D., & Estefan, A. (2020) · Journal of Mental Health and Addiction Nursing · doi:10.22374/jmhan.v4i1.40 · Cited by 11
Fagetti, A., & Mercadillo, R. E. (2022) · Anthropology of Consciousness · doi:10.1111/anoc.12163 · Cited by 12
Self-Care Practices with Psychedelics–A Qualitative Study of Users’ Perspectives
Soares, C. M., Leite, Â., & Pinto, M. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2071134 · Cited by 10
Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon
Bellman, V. (2024) · Cancers · doi:10.3390/cancers16091702 · Cited by 11
The library is open: a scoping review on queer representation in psychedelic research
Bartlett, A., Christ, C., Martins, B. S., Saxberg, K., & Ching, T. H. W. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1472559 · Cited by 11
Designing Consciousness: Psychedelics as Ontological Design Tools for Decolonizing Consciousness
Falcon, J. (2020) · Design and Culture · doi:10.1080/17547075.2020.1826182 · Cited by 13
Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa
Rodan, S.-C., Aouad, P., McGregor, I. S., & Maguire, S. (2021) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2102102 · Cited by 12
Efthimiou, A. A., Cardinale, A. M., & Kepa, A. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2023.0058 · Cited by 11
Stroud, J., Rice, C., Orsini, A., Schlosser, M., Lee, J., Mandy, W., & Kamboj, S. K. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06685-8 · Cited by 11
Existential feelings as a phenomenological framework for psychedelic therapy
Tijhuis, F. B., Coninx, S., & de Bruin, L. C. (2024) · Philosophical Psychology · doi:10.1080/09515089.2024.2412195 · Cited by 10
Rose, J. R. (2024) · Sociology of Health & Illness · doi:10.1111/1467-9566.13872 · Cited by 9
Healy, C. J., Frazier, A., Kirsch, S., Sanford, A., Garcia‐Romeu, A., Todman, M., Varon, J. P., & D'Andrea, W. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111361 · Cited by 9
Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder
Davis, A. K., DellaCrosse, M. A., Sepeda, N. D., Levin, A. W., Cosimano, M. P., Shaub, H., Washington, T., Gooch, P. M., Gilead, S., Gaughan, S. J., et al. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00461 · Cited by 9
Evidence versus expectancy: the development of psilocybin therapy
Rucker, J. (2023) · BJPsych Bulletin · doi:10.1192/bjb.2023.28 · Cited by 9
Nicholas, C. R. N., Horton, D. M., Malicki, J., Baltes, A., Hutson, P. R., & Brown, R. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2023.0012 · Cited by 10
An evaluation of the role of mystical experiences in transpersonal ecopsychology
Harrild, F., & Luke, D. P. (2020) · Transpersonal Psychology Review · doi:10.53841/bpstran.2020.22.1.45 · Cited by 9
Muscat, S.-A., Hartelius, G., Crouch, C., & Morin, K. W. (2022) · Psych · doi:10.3390/psych4010012 · Cited by 11
Smith, F. N., Neill, J. C., & Wainwright, V. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221124117 · Cited by 10
Olofsson, M., Osika, W., Goldberg, S. B., Hendricks, P. S., Petrović, P., White, T. J. H., Stenfors, C. U. D., Chaturvedi, S., & Simonsson, O. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.105105 · Cited by 10
Microbiome: The Next Frontier in Psychedelic Renaissance
Kargbo, R. B. (2023) · Journal of Xenobiotics · doi:10.3390/jox13030025 · Cited by 9
EMBARK Psychedelic Therapy for Depression
Brennan, B., & Belser, A. (2024) · doi:10.1093/9780197762622.001.0001 · Cited by 8
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Trials · doi:10.1186/s13063-024-08174-x · Cited by 10
Psychothérapie augmentée par la kétamine (KAP) dans les troubles de l’humeur : mode d’emploi
Bottemanne, H., Baldacci, A., Muller, C., Boyreau, A., & Claret, A. (2021) · L Encéphale · doi:10.1016/j.encep.2021.08.011 · Cited by 9
Hendricks, P. S., Copes, H., Family, N., Williams, L. T. J., Luke, D. P., & Raz, S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211055855 · Cited by 9
Deane, G., Mago, J., Fotopoulou, A., Sacchet, M. D., Carhart-Harris, R. L., & Sandved-Smith, L. (2024) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/x7aew · Cited by 11
Self-citationArmand, S., Larsen, K., Madsen, M. K., Ozenne, B., Preller, K. H., Knudsen, G. M., Stenbæk, D. S., & Fisher, P. M. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103934 · Cited by 7
Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence
Piercey, C. J., Gray, B. A., Sung, A., Henry, D., & Karoly, H. C. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2023.0052 · Cited by 7
Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples
Graziosi, M., Rohde, J. S., Lake, S., Lucas, P., Kaufman, S. B., & Yaden, D. B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314469 · Cited by 10
Tadmor, N., Halperin, D., & Simon, G. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00372 · Cited by 7
“Ontological shocks”: new transformations for sustainability through psychedelic tourism
Coghlan, A., & Prayag, G. (2025) · Journal of Sustainable Tourism · doi:10.1080/09669582.2025.2493313 · Cited by 7
Biscoe, N., Bonson, A., Slavin, M., Busuttil, W., MacManus, D., Cox, A., & Murphy, D. (2023) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2023.100359 · Cited by 8
Psychedelic intimacy: Altered states of consciousness in romantic relationships
Neubert, J. J., Anderson, K., & Mason, N. L. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00319 · Cited by 7
Hooyer, K., Applbaum, K., & Kasza, D. (2020) · Journal of Humanistic Psychology · doi:10.1177/0022167820904523 · Cited by 7
Muscat, S.-A., Wright, G. D., Bergeron, K., Morin, K. W., Crouch, C., & Hartelius, G. (2021) · Behavioral Sciences · doi:10.3390/bs11090118 · Cited by 8
Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P., Bruno, R., Wenge, T., & Bright, S. J. (2023) · Journal of Humanistic Psychology · doi:10.1177/00221678231168516 · Cited by 9
Metadata
- Authors
- Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Watts, Rosalind
- Venue
- Journal of Humanistic Psychology
- Publisher
- SAGE Publications
- Published
- 2017-06-19
- Volume
- 57
- Issue
- 5
- Pages
- 520-564
- ISSN
- 0022-1678 (ISSN-L)
- 1552-650X
- OpenAlex
- W2644260506
- Cited by
- 589
- References
- 54
- Citations by year
- 2026: 80 · 2025: 86 · 2024: 87 · 2023: 100 · 2022: 84 · 2021: 72 · 2020: 34 · 2019: 19 · 2018: 20 · 2017: 6
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Humanistic Psychology (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, treatment-resistant depression, patient experience, connectedness, acceptance, disconnection, emotional avoidance, antidepressants, psychotherapy, psychedelic therapy, mechanisms of change
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
